Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results , but sales fell by 5.6% year on year to ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Bristol Myers Squibb plans to inject $40 billion into U.S. operations over the next five years, mixing business ambition with ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer ...

Bristol Myers Squibb plans to invest a jaw-dropping $40 billion in the U.S. over five years to reinforce its research, tech, ...